Investors

Investors

Corporate Profile

Ocugen, Inc. is a clinical-stage biotechnology company focused on discovering, developing, and commercializing gene therapies, biologicals and vaccines that improve health and offer hope for people and global communities. We are making an impact through courageous innovation, taking science in new directions in service of patients. Our breakthrough modifier gene therapy platform has the potential to treat multiple diseases with one drug and we are advancing research in other therapeutic areas to offer new options for people with unmet medical needs.

Stock Quote & Chart

Change
Volume
Today’s Open
Previous Close
Market Cap
Today’s High
Today’s Low
52 Week High
52 Week Low

Data Provided by Refinitiv. Minimum 15 minutes delayed.